Oral History

Researchers use DNA from ancient tooth tartar to chart changes in the bacterial communities that have lived in human mouths for 8,000 years.

Written byDan Cossins
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

GENETIC ARCHAEOLOGY: A matchbox-size chunk of dental tartar cut from this 1,000-year-old jaw inspired the study of differences in the oral bacterial communities of early and modern humans.COURTESY OF ALAN COOPERThe idea took root with the offer of an unusual gift—a hefty chunk of ancient dental tartar. In 1996, while a postdoc at the University of Oxford, biological anthropologist Alan Cooper visited archaeologist Keith Dobney at York University. They had already discussed several ideas, including how they might use ancient tartar—otherwise known as dental calculus—when Dobney pulled from his desk drawer a matchbox-size brownish-grey block of the stuff, taken from a 1,000-year-old skeleton. “I was amazed,” recalls Cooper.

Dobney, now at the University of Aberdeen in Scotland, had been using scanning electron microscopy to examine the calculus for traces of food when he noticed an abundance of fossilized bacteria. He suggested it might also be a source of extractable bacterial DNA—a prize that could offer a glimpse into the evolution of the human microbiota and of human disease. Cooper was keen to try, but knew that even the most sterile lab consumables—from plasticware to enzymes—contained traces of bacterial DNA, so he was never confident that his early results were free from contamination.

Almost 2 decades later, armed with ultrasterile consumables and an ultraclean lab at the University of Adelaide’s Australian Centre for Ancient DNA—where he is now director—Cooper and his colleagues have used ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies